Government ❯ Health Policy

Drug Regulation

FDA Public Safety Quality Control Public Health Initiatives Public Health Investigations Pharmaceutical Oversight Public Health Safety Opioid Legislation Public Health Response

India Bans High‑Dose Oral Nimesulide as States Begin Enforcement

Regulators invoked Section 26A after expert reviews flagged hepatotoxicity, with safer options available.

India Proposes Rule To Make Cough Syrups Prescription-Only

CDSCO Flags 205 Drug Samples as Not of Standard Quality in November

Neuquén Declares Health Alert After Two Deaths Linked to Suspected Adulterated Cocaine

FDA Names Tracy Beth Høeg Acting CDER Director as OTC Drugs Chief Is Reassigned

ED Attaches Chennai Flats of Coldrif Maker in Toxic Cough Syrup Case

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Health Minister and ANMAT Chief Skip Fentanyl Hearing as Congress Sets December 9 Reform Report

Baby Hospitalized After Suspected Fentanyl Overdose on San Francisco’s Treasure Island

India Weighs Stricter Controls on Cough Syrup Sales After Contamination Deaths

Japan Designates Three Dangerous-Drug Components as Designated Drugs, Ban Takes Effect Nov. 8

Salford Woman's Death After £20 'Skinny Jab' Triggers Two Arrests and Official Crackdown

Pharma Rep Held in Coldrif Child-Death Probe as Punjab Bans 112 Substandard Drugs

New CMAJ Papers Highlight Rising Youth Opioid Harm as Prescribing Declines

Streeck Presses to Tighten Germany’s Cannabis Rules as CDU Plans to Reopen Law

Japan Approves First Over-the-Counter Morning-After Pill

Drug Deaths Hit Record High as Nitazene Fatalities Nearly Quadruple

FDA Names First 9 Drugs for ‘National Priority’ Fast-Track Reviews, Targeting 1–2-Month Decisions

India Cough Syrup Crisis Pushes Child Death Toll to 24 in Madhya Pradesh

FDA Launches Mifepristone Safety Review, Weighing How the Drug Is Dispensed